Old Web
English
Sign In
Acemap
>
authorDetail
>
Scott T Tagawa
Scott T Tagawa
Medicine
Internal medicine
Oncology
Urology
Prostate cancer
4
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TROPHY-u-01: A phase II open-label study of sacituzumab govitecan (IMMU-132) in patients with advanced urothelial cancer after progression on platinum-based chemotherapy and/or anti-PD-1/PD-L1 checkpoint inhibitor therapy.
2019
Journal of Clinical Oncology
Scott T Tagawa
Daniel P. Petrylak
Petros Grivas
Neeraj Agarwal
Cora N. Sternberg
Chris Hernandez
Peggy Siemon-Hryczyk
Trishna Goswami
Yohann Loriot
Show All
Source
Cite
Save
Citations (9)
Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy: Accurate preoperative prediction of non-organ-confined UCB at cystectomy
2013
BJUI
David A. Green
Michael Rink
Jens Hansen
Eugene K. Cha
Brian D. Robinson
Zhe Tian
Felix K.-H. Chun
Scott T Tagawa
Pierre I. Karakiewicz
Margit Fisch
Douglas S. Scherr
Shahrokh F. Shariat
Show All
Source
Cite
Save
Citations (0)
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC): NOVEL THERAPIES FOR CASTRATION-RESISTANT PROSTATE CANCER
2012
BJUI
Daniel J. Lee
Eugene K. Cha
Justin M. Dubin
Himisha Beltran
Thomas F. Chromecki
Harun Fajkovic
Douglas S. Scherr
Scott T Tagawa
Shahrokh F. Shariat
Show All
Source
Cite
Save
Citations (0)
A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High-Risk Castrate, Biochemically Relapsed Prostate Cancer
2011
Scott T Tagawa
Show All
Source
Cite
Save
Citations (0)
1